Japan's Astellas Pharma considers selling Europe assets to raise cash

Japan's Astellas Pharma considers selling Europe assets to raise cash

Visual from Astellas' website

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter